Article related to sinovac-biotech | AWANI International
LIVE
Videos
US-China
BRICS-RT
ASEAN
West Asia
Shows
Podcast
BM
EN
LIVE
Login
BM
EN
LIVE
Login
LIVE
Videos
US-China
BRICS-RT
ASEAN
West Asia
Shows
Podcast
FIFA launches annual Peace Prize for World Cup draw with Trump a contender
Canada and Mexico should not be export hubs for China, says USTR
Kremlin says Russia is encouraged by talks with US, ready to engage further
Sinovac Biotech
Latest research shows three doses of Sinovac vaccine effective against Omicron
22/01/2022
Sinovac says its vaccine effective against Delta variant
23/07/2021
Sinovac's COVID-19 vaccine gains China approval for emergency use in children, adolescents
05/06/2021
Sinovac vaccine contribution to Penang doubtful, company non-existent
19/05/2021
Indonesia study finds China's Sinovac COVID-19 vaccine effective in medical staff
12/05/2021
Sinovac supplied 260 million COVID-19 vaccine doses globally
20/04/2021
China considers mixing COVID-19 vaccines to boost protection rate
13/04/2021
Hong Kong halts Pfizer/BioNTech COVID-19 vaccines, investigates packaging
24/03/2021
A year after first case, Brazil hurtles past 250,000 COVID-19 deaths
26/02/2021
China approves Sinovac Biotech COVID-19 vaccine for general public use
06/02/2021
China to provide 10 million vaccine doses to COVAX initiative
03/02/2021
Turkey approves China-based Sinovac vaccine's emergency use
14/01/2021
China's Sinovac defends COVID-19 vaccine after disappointing Brazil data
13/01/2021
Malaysia to study Sinovac clinical trial data before approving vaccine
13/01/2021
Wariness in Indonesia as Chinese Sinovac COVID-19 jabs start
13/01/2021
Indonesia launches vaccination drive as COVID-19 deaths hit record
13/01/2021
What you need to know about the coronavirus right now
13/01/2021
Over 4 million COVID-19 vaccine doses from China's CNBG administered in emergency use
09/01/2021
China to vaccinate 50 million people for Lunar New Year - SCMP
18/12/2020
China to vaccinate 50 million people for Lunar New Year - SCMP
18/12/2020
Show More
